Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Creatine Treatment in Psychiatric Disorders

This study has been completed.
Sponsor:
Collaborator:
National Alliance for Research on Schizophrenia and Depression
Information provided by:
Beersheva Mental Health Center
ClinicalTrials.gov Identifier:
NCT00140192
First received: August 31, 2005
Last updated: July 28, 2009
Last verified: October 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2006
  Primary Completion Date: March 2006 (Final data collection date for primary outcome measure)
No publications provided by Beersheva Mental Health Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):